New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
15:20 EDTACT, FURXFuriex stockholders approve acquisition by Actavis
The stockholders of Furiex Pharmaceuticals (FURX) voted at a special meeting to adopt the previously announced agreement and plan of merger, dated as of April 27, providing for the merger of Furiex with an entity now controlled by Forest Laboratories, a subsidiary of Actavis (ACT). Furiex also announced that it has received notice of clearance of the proposed merger from the Ukrainian Antimonopoly Committee. Actavis completed its acquisition of Forest Laboratories on July 1.
News For FURX;ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 17, 2014
09:22 EDTACTOn The Fly: Pre-market Movers
Subscribe for More Information
09:21 EDTACTActavis, Allergan transaction subject to approval of shareholders of both
Subscribe for More Information
09:20 EDTACTActavis projects at least $1.8B in annual synergies from Allergan transaction
Subscribe for More Information
09:18 EDTACTActavis sees free cash flow over $8B in 2016 following Allergan acquisition
Subscribe for More Information
09:16 EDTACTActavis confirms deal to acquire Allergan for $219 in cash, stock
Subscribe for More Information
09:15 EDTACTActavis confirms deal to acquire Allergan for $219 in cash and shares
Subscribe for More Information
09:10 EDTACTActavis buying Allergan for $219 per share, CNBC reports
08:02 EDTACTActavis completes Durata Therapeutics tender offer
Subscribe for More Information
06:05 EDTACTActavis close to buying Allergan for over $64B, Bloomberg reports
Subscribe for More Information
November 16, 2014
14:02 EDTACTAllergan, Actavis move closer to deal, WSJ reports
Subscribe for More Information
November 14, 2014
16:58 EDTACTThird Point gives quarterly update on stakes
NEW STAKES: Alibaba (BABA), eBay (EBAY), Bed Bath & Beyond (BBBY), Shire (SHPG), and Parker Hannifin (PH). INCREASED STAKES: Actavis (ACT), Amgen (AMGN), EQT (EQT), Sensata (ST), Coca-Cola Enterprises (CCE). DECREASED STAKES: Williams Cos (WMB), Ally Financial (ALLY), Cheniere Energy (LNG), YPF (YPF), and FedEx (FDX). LIQUIDATED STAKES: AIG (AIG), T-Mobile (TMUS), Rackspace (RAX), Hertz (HTZ), and Citrix Systems (CTXS).
12:53 EDTACTOmega Advisors gives quarterly update on stakes
NEW STAKES: AerCap Holdings (AER), Nordic American Offshore (NAO), Melco Crown Entertainment (MPEL), Groupon (GRPN), and Ashland (ASH). INCREASED STAKES: QEP Resources (QEP), United Continental (UAL), Cabot Oil & Gas (COG), Actavis (ACT), and KAR Auction Services (KAR). DECREASED STAKES: Sprint (S), SandRidge Energy (SD), Sirius XM Holdings (SIRI), Kinder Morgan (KMI), and Transocean (RIG). LIQUIDATED STAKES: QUALCOMM (QCOM), Ocwen Financial (OCN), Freeport-McMoRan (FCX), Boston Scientific (BSX), and Capital One (COF).
07:32 EDTACTHayman Capital gives quarterly update on stakes
Subscribe for More Information
November 13, 2014
10:44 EDTACTMallinckrodt news on generic Concerta positive for Actavis, says BMO Capital
Subscribe for More Information
08:15 EDTACTActavis' sNDA for bipolar disorder candidate Saphris accepted by FDA
Subscribe for More Information
07:23 EDTACTValeant wooing doctors ahead of hoped for Allergan acquisition, WSJ says
Subscribe for More Information
November 12, 2014
10:09 EDTACTActavis in talks to buy Allergan for over $200 per share, Bloomberg says
Subscribe for More Information
10:01 EDTACTActavis in talks to buy Allergan for $60B, more than $200/share Bloomberg says
Actavis (ACT) is said to seek to pay about $200 per share, but Allergan (AGN) seeks about $210 per share, according to Bloomberg.
November 11, 2014
08:32 EDTACTValeant likely to raise offer for Allergan again, says Bernstein
Subscribe for More Information
November 10, 2014
16:34 EDTACTActavis appoints Maria Teresa Hilado as CFO
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use